Search hospitals
>
District of Columbia
>
Washington
MedStar Washington Hospital Center
Claim this profile
Washington, District of Columbia 20010
Global Leader in Breast Cancer
Global Leader in Coronary Artery Disease
Conducts research for Heart Failure
Conducts research for Stroke
Conducts research for Atrial Fibrillation
626 reported clinical trials
75 medical researchers
Summary
MedStar Washington Hospital Center is a medical facility located in Washington, District of Columbia. This center is recognized for care of Breast Cancer, Coronary Artery Disease, Heart Failure, Stroke, Atrial Fibrillation and other specialties. MedStar Washington Hospital Center is involved with conducting 626 clinical trials across 728 conditions. There are 75 research doctors associated with this hospital, such as Ron Waksman, M.D., Anteneh A. Tesfaye, Benjamin A. Weinberg, and Stephen V. Liu.
Area of expertise
Breast Cancer
MedStar Washington Hospital Center has run 58 trials for Breast Cancer. Some of their research focus areas include:
Coronary Artery Disease
MedStar Washington Hospital Center has run 52 trials for Coronary Artery Disease.
Top PIs
Ron Waksman, M.D.
MedStar Washington Hospital Center
7 years of reported clinical research
Anteneh A. Tesfaye
Wayne State University/Karmanos Cancer Institute
6 years of reported clinical research
Benjamin A. Weinberg
MedStar Georgetown University Hospital
2 years of reported clinical research
Stephen V. Liu
MedStar Georgetown University Hospital
9 years of reported clinical research
Clinical Trials running at MedStar Washington Hospital Center
Breast Cancer
Bladder Cancer
Lung Cancer
Atrial Fibrillation
Stroke
Prostate Cancer
Kidney Cancer
Cutaneous Melanoma
Melanoma
Pancreatic Cancer
PF-07220060 + Letrozole
for Breast Cancer
The purpose of this study is to determine the safety and efficacy of PF-07220060 with letrozole compared to approved treatments (ie, palbociclib, ribociclib or abemaciclib with letrozole) in people with breast cancer: * HR-positive (breast cancer cells that need estrogen or progesterone to grow) * HER2-negative (cells that have a small amount or none of a protein called HER2 on their surface); * locally advanced (that has spread from where it started to nearby tissue or lymph nodes) or metastatic disease (the spread of cancer to other places in the body) * who have not received any prior systemic anti-cancer treatment for advanced/metastatic disease. Approximately half of the participants will receive PF-07220060 plus letrozole while the other half of participants will receive the investigator's choice of treatment plus letrozole. The study team will monitor how each participant is doing with the study treatment during regular visits at the study clinic.
Recruiting
2 awards
Phase 3
4 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting
2 awards
Phase 3
19 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting
2 awards
Phase 3
19 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at MedStar Washington Hospital Center?
MedStar Washington Hospital Center is a medical facility located in Washington, District of Columbia. This center is recognized for care of Breast Cancer, Coronary Artery Disease, Heart Failure, Stroke, Atrial Fibrillation and other specialties. MedStar Washington Hospital Center is involved with conducting 626 clinical trials across 728 conditions. There are 75 research doctors associated with this hospital, such as Ron Waksman, M.D., Anteneh A. Tesfaye, Benjamin A. Weinberg, and Stephen V. Liu.
Where is MedStar Washington Hospital Center located?
To reach MedStar Washington Hospital Center in Washington, D.C., head north on 16th Street NW, turn right at Irving Street NW, and follow it as it curves around the back of the hospital campus. Then, turn right at First Street NW and follow signs to parking.
Who should I call to ask about financial aid or insurance network?
For financial assistance at MedStar Washington Hospital Center, contact the Customer Service Division at 410-933-4966 or toll-free at 844-817-6087, available Monday through Friday, 8 a.m. to 6 p.m. For insurance-related inquiries, contact your insurance provider directly or learn about MedStar Family Choice for Maryland or DC Medicaid eligibility. The main hospital telephone number is 202-877-7000.
What insurance does MedStar Washington Hospital Center accept?
MedStar Washington Hospital Center offers comprehensive benefits for its employees, including medical, dental, and vision plans. For MedStar Health Home Care, accepted insurance plans are Aetna, Amerigroup (Maryland), CareFirst BlueCross BlueShield, Cigna Health Springs, Kaiser, Medicaid (DC, Maryland, Virginia), Medicare, MedStar Family Choice MD and DC, MedStar Select, TRICARE, and United Healthcare. MedStar Select is exclusively available to MedStar Health associates and their families, providing both in-network and out-of-network coverage.
What awards or recognition has MedStar Washington Hospital Center received?
MedStar Washington Hospital Center is renowned for its excellence in healthcare, consistently ranked among the nation's top 50 hospitals for cardiology and heart surgery by U.S. News & World Report. It has also earned recognition as a top 50 cardiovascular center, with high-performing specialties in nephrology and urology. The hospital's Perinatal Center is accredited by the American Institute of Ultrasound Medicine, and its critical care units have received the Silver Beacon Award for Excellence from the American Association of Critical-Care Nurses.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.